237 related articles for article (PubMed ID: 20427502)
21. Potential use of data-mining algorithms for the detection of 'surprise' adverse drug reactions.
Hauben M; Horn S; Reich L
Drug Saf; 2007; 30(2):143-55. PubMed ID: 17253879
[TBL] [Abstract][Full Text] [Related]
22. Risk of hepatotoxicity associated with the use of telithromycin: a signal detection using data mining algorithms.
Chen Y; Guo JJ; Healy DP; Lin X; Patel NC
Ann Pharmacother; 2008 Dec; 42(12):1791-6. PubMed ID: 19033479
[TBL] [Abstract][Full Text] [Related]
23. Unusual complications of antithyroid drug therapy: four case reports and review of literature.
Baker B; Shapiro B; Fig LM; Woodbury D; Sisson JC; Beierwaltes WH
Thyroidology; 1989 Apr; 1(1):17-26. PubMed ID: 2484903
[TBL] [Abstract][Full Text] [Related]
24. Putting propylthiouracil in perspective.
Cooper DS; Rivkees SA
J Clin Endocrinol Metab; 2009 Jun; 94(6):1881-2. PubMed ID: 19401361
[No Abstract] [Full Text] [Related]
25. [Pharmacotherapy of hyperthyreosis--adverse drug reactions].
Perger L; Bürgi U; Fattinger K
Ther Umsch; 2011 Jun; 68(6):303-8. PubMed ID: 21656488
[TBL] [Abstract][Full Text] [Related]
26. Liver injury due to endothelin receptor antagonists: a real-world study based on post-marketing drug monitoring data.
Dong S; Guo X; Wang H; Sun C
Ther Adv Respir Dis; 2024; 18():17534666231223606. PubMed ID: 38179676
[TBL] [Abstract][Full Text] [Related]
27. Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitides.
Bonaci-Nikolic B; Nikolic MM; Andrejevic S; Zoric S; Bukilica M
Arthritis Res Ther; 2005; 7(5):R1072-81. PubMed ID: 16207324
[TBL] [Abstract][Full Text] [Related]
28. Risk of congenital anomalies associated with antithyroid treatment during pregnancy: a meta-analysis.
Li X; Liu GY; Ma JL; Zhou L
Clinics (Sao Paulo); 2015 Jun; 70(6):453-9. PubMed ID: 26106966
[TBL] [Abstract][Full Text] [Related]
29. Pathogenesis of propylthiouracil-related hepatotoxicity in children: present concepts.
Karras S; Memi E; Kintiraki E; Krassas GE
J Pediatr Endocrinol Metab; 2012; 25(7-8):623-30. PubMed ID: 23155684
[TBL] [Abstract][Full Text] [Related]
30. Adjunctive topiramate enhances the risk of hypothermia associated with valproic acid therapy.
Knudsen JF; Sokol GH; Flowers CM
J Clin Pharm Ther; 2008 Oct; 33(5):513-9. PubMed ID: 18834366
[TBL] [Abstract][Full Text] [Related]
31. [A case of insulin autoimmune syndrome with cholestatic hepatitis induced by methimazole and propylthiouracil].
Kimura T; Shindo T
Nihon Naika Gakkai Zasshi; 1982 May; 71(5):685-91. PubMed ID: 7130811
[No Abstract] [Full Text] [Related]
32. [Acute cholestatic hepatitis induced by propylthiouracil. Case report].
Parolin MB; Lopes RW; Telles JE; Ioshii SO; Hajar N
Arq Gastroenterol; 2000; 37(2):129-32. PubMed ID: 11144016
[TBL] [Abstract][Full Text] [Related]
33. Outcome of pediatric Graves' disease after treatment with antithyroid medication and radioiodine.
Ward L; Huot C; Lambert R; Deal C; Collu R; Van Vliet G
Clin Invest Med; 1999 Aug; 22(4):132-9. PubMed ID: 10497711
[TBL] [Abstract][Full Text] [Related]
34. Endotoxin-like reactions with intravenous gentamicin: results from pharmacovigilance tools under investigation.
Hauben M; Reich L
Infect Control Hosp Epidemiol; 2005 Apr; 26(4):391-4. PubMed ID: 15865275
[TBL] [Abstract][Full Text] [Related]
35. Comparison of methimazole and propylthiouracil in patients with hyperthyroidism caused by Graves' disease.
Nakamura H; Noh JY; Itoh K; Fukata S; Miyauchi A; Hamada N
J Clin Endocrinol Metab; 2007 Jun; 92(6):2157-62. PubMed ID: 17389704
[TBL] [Abstract][Full Text] [Related]
36. Antithyroid drug treatment for graves' disease in children: a long-term retrospective study at a single institution.
Ohye H; Minagawa A; Noh JY; Mukasa K; Kunii Y; Watanabe N; Matsumoto M; Suzuki M; Yoshihara A; Ito K; Ito K
Thyroid; 2014 Feb; 24(2):200-7. PubMed ID: 23926918
[TBL] [Abstract][Full Text] [Related]
37. Antipsychotics, glycemic disorders, and life-threatening diabetic events: a Bayesian data-mining analysis of the FDA adverse event reporting system (1968-2004).
DuMouchel W; Fram D; Yang X; Mahmoud RA; Grogg AL; Engelhart L; Ramaswamy K
Ann Clin Psychiatry; 2008; 20(1):21-31. PubMed ID: 18297583
[TBL] [Abstract][Full Text] [Related]
38. Desensitization to Methimazole.
Mazhari A; Emanuele MA; Espiritu B
Endocr Pract; 2021 Mar; 27(3):185-190. PubMed ID: 33779553
[TBL] [Abstract][Full Text] [Related]
39. Propylthiouracil-induced hepatotoxicity.
Hardee JT; Barnett AL; Thannoun A; Eghtesad B; Wheeler D; Jamal MM
West J Med; 1996 Sep; 165(3):144-7. PubMed ID: 8909171
[No Abstract] [Full Text] [Related]
40. Commonality of drug-associated adverse events detected by 4 commonly used data mining algorithms.
Sakaeda T; Kadoyama K; Minami K; Okuno Y
Int J Med Sci; 2014; 11(5):461-5. PubMed ID: 24688309
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]